Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review

Detalhes bibliográficos
Autor(a) principal: Guimarães, Ademara
Data de Publicação: 2024
Outros Autores: Araujo, Camila, Soares Neto, Francisco, Cruz, Marcella Pimenta Pereira, Silva, Thames Dantas da, Diniz, Isabela Guerreiro, Guimarães, Márcia Cristina Monteiro
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/44866
Resumo: The aim was to analyze the use of cannabidiol as a medicinal treatment for chronic pain by means of an integrative review. This is an Integrative Literature Review (ILR), which set out to identify, synthesize and carry out an extended analysis of the herbal use of cannabidiol. Thirty pieces of literature were selected for full reading and presentation of the results, as they met the objectives. The samples came from 85% of the Medline/PubMed database, in the last five years, with 60% of them using a cross-sectional approach and descriptive nature, and 84% of the patients studied in the studies reported an improvement in the level of chronic and/or neuropathic pain after starting to use Cannabis. In addition to this benefit, others mentioned in the articles were improved sleep and its quality, as well as reduced opioid consumption. With regard to the origin of the pain, half said it was linked to one or more causes, and chronic pain including cancer (nonspecific, intractable and other) was the most mentioned (80%). There is important consensus that medical cannabis can be approved for populations with inflammatory, nociplastic, neuropathic and mixed pain, however, if you are considering using CBD to treat chronic pain or any other MMJ-based condition, it is essential to discuss this with a doctor or healthcare professional to ensure that it is safe and appropriate for your specific situation. In this sense, more studies should be carried out to prove the importance and effectiveness of cannabidiol in the treatment of chronic pain, both from a clinical, review and statistical point of view.
id UNIFEI_89a2c43ff6223d9ffe15c7287afb46e4
oai_identifier_str oai:ojs.pkp.sfu.ca:article/44866
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Cannabidiol as a phytopharmaceutical for chronic pain: Integrative reviewCannabidiol como fitofármaco para el dolor crónico: Revisión integradoraCanabidiol como fitofármaco da dor crônica: Revisão integrativa PhytodrugsCannabis sativaChronic pain treatmentReview.FitofármacosCannabis sativaTratamiento del dolor crónicoRevisión.FitofármacoCannabis sativaTratamento dor crônicaRevisão.The aim was to analyze the use of cannabidiol as a medicinal treatment for chronic pain by means of an integrative review. This is an Integrative Literature Review (ILR), which set out to identify, synthesize and carry out an extended analysis of the herbal use of cannabidiol. Thirty pieces of literature were selected for full reading and presentation of the results, as they met the objectives. The samples came from 85% of the Medline/PubMed database, in the last five years, with 60% of them using a cross-sectional approach and descriptive nature, and 84% of the patients studied in the studies reported an improvement in the level of chronic and/or neuropathic pain after starting to use Cannabis. In addition to this benefit, others mentioned in the articles were improved sleep and its quality, as well as reduced opioid consumption. With regard to the origin of the pain, half said it was linked to one or more causes, and chronic pain including cancer (nonspecific, intractable and other) was the most mentioned (80%). There is important consensus that medical cannabis can be approved for populations with inflammatory, nociplastic, neuropathic and mixed pain, however, if you are considering using CBD to treat chronic pain or any other MMJ-based condition, it is essential to discuss this with a doctor or healthcare professional to ensure that it is safe and appropriate for your specific situation. In this sense, more studies should be carried out to prove the importance and effectiveness of cannabidiol in the treatment of chronic pain, both from a clinical, review and statistical point of view.El objetivo era analizar el uso del cannabidiol como tratamiento medicinal del dolor crónico mediante una revisión integradora. Se trata de una Revisión Integrativa de la Literatura (RIL), que se propuso identificar, sintetizar y llevar a cabo un análisis ampliado del uso herbal del cannabidiol. Se seleccionaron 30 trabajos para su lectura completa y la presentación de los resultados, ya que cumplían los objetivos. Las muestras procedían en 85% de la base de datos Medline/PubMed, en los últimos cinco años, con 60% de ellas con enfoque transversal y de carácter descriptivo, y el 84% de los pacientes estudiados en los estudios informaron de una mejora en el nivel de dolor crónico y/o neuropático después de comenzar a usar Cannabis. Además de este beneficio, otros mencionados en los artículos fueron la mejora del sueño y de su calidad, así como la reducción del consumo de opioides. En cuanto al origen del dolor, la mitad dijo que estaba relacionado con una o más causas, y dolor crónico, incluido el cáncer (inespecífico, intratable y otros) fue el más mencionado, con un 80%. Existe un importante consenso que el cannabis medicinal puede ser aprobado para personas con dolor inflamatorio, nociplásico, neuropático y mixto, sin embargo, si estás considerando usar CBD para tratar el dolor crónico o cualquier otra condición basada en MMJ, es esencial que lo discutas un médico o profesional de salud para asegurarte de que seguro y apropiado para tu situación específica. Este sentido, deberían realizarse más estudios para demostrar la importancia y eficacia del cannabidiol en el tratamiento del dolor crónico, tanto desde un punto de vista clínico, como de revisión y estadístico.Objetivou analisar o uso do canabidiol como tratamento medicamentoso de dor crônica, por meio de uma revisão integrativa. Trata-se de uma Revisão Integrativa de Literatura (RIL), que se propôs identificar, sintetizar e realizar uma análise ampliada acerca do uso fitoterápico do Canabidiol. Selecionou-se 30 literaturas para leitura integral e apresentação dos resultados, pois, responderam aos objetivos. As amostras foram provenientes em 85% da base Medline/PubMed, nos últimos cinco anos, com 60% destes utilizando método de abordagem transversal e caráter descritivo, e 84% dos pacientes estudados nas pesquisas relataram melhora do nível de dor crônica e/ou neuropática após iniciar o uso de Cannabis. Além desse benefício, outros mencionados nos artigos foram a melhora do sono e da sua qualidade, além da redução do consumo de opioides. No que tange a origem da dor, a literatura afirmou estar ligadas a uma ou mais causas, e a crônica incluindo a cancerígena (inespecífica, intratável e outros) foi a mais mencionada em 80%. Há importante consenso de que a cannabis medicinal pode ser aprovada para população com dor inflamatória, nociplástica, neuropática e mista, entretanto, for considerado o uso do CBD para tratar dor crônica ou qualquer outra condição a base de MMJ, é essencial discutir isso com um médico ou profissional de saúde para garantir que seja seguro e apropriado para a sua situação específica. Nesse sentido, mais estudos devem ser realizados para comprovar a importância e eficácia do canabidiol no tratamento da dor crônica, tanto do ponto de vista clínico, revisão e estatístico.Research, Society and Development2024-01-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4486610.33448/rsd-v13i1.44866Research, Society and Development; Vol. 13 No. 1; e12413144866Research, Society and Development; Vol. 13 Núm. 1; e12413144866Research, Society and Development; v. 13 n. 1; e124131448662525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/44866/35842Copyright (c) 2024 Ademara Guimarães; Camila Araujo; Francisco Soares Neto; Marcella Pimenta Pereira Cruz; Thames Dantas da Silva; Isabela Guerreiro Diniz; Márcia Cristina Monteiro Guimarãeshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGuimarães, Ademara Araujo, Camila Soares Neto, Francisco Cruz, Marcella Pimenta Pereira Silva, Thames Dantas da Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro 2024-02-01T09:48:39Zoai:ojs.pkp.sfu.ca:article/44866Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-02-01T09:48:39Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
Cannabidiol como fitofármaco para el dolor crónico: Revisión integradora
Canabidiol como fitofármaco da dor crônica: Revisão integrativa
title Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
spellingShingle Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
Guimarães, Ademara
Phytodrugs
Cannabis sativa
Chronic pain treatment
Review.
Fitofármacos
Cannabis sativa
Tratamiento del dolor crónico
Revisión.
Fitofármaco
Cannabis sativa
Tratamento dor crônica
Revisão.
title_short Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
title_full Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
title_fullStr Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
title_full_unstemmed Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
title_sort Cannabidiol as a phytopharmaceutical for chronic pain: Integrative review
author Guimarães, Ademara
author_facet Guimarães, Ademara
Araujo, Camila
Soares Neto, Francisco
Cruz, Marcella Pimenta Pereira
Silva, Thames Dantas da
Diniz, Isabela Guerreiro
Guimarães, Márcia Cristina Monteiro
author_role author
author2 Araujo, Camila
Soares Neto, Francisco
Cruz, Marcella Pimenta Pereira
Silva, Thames Dantas da
Diniz, Isabela Guerreiro
Guimarães, Márcia Cristina Monteiro
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Guimarães, Ademara
Araujo, Camila
Soares Neto, Francisco
Cruz, Marcella Pimenta Pereira
Silva, Thames Dantas da
Diniz, Isabela Guerreiro
Guimarães, Márcia Cristina Monteiro
dc.subject.por.fl_str_mv Phytodrugs
Cannabis sativa
Chronic pain treatment
Review.
Fitofármacos
Cannabis sativa
Tratamiento del dolor crónico
Revisión.
Fitofármaco
Cannabis sativa
Tratamento dor crônica
Revisão.
topic Phytodrugs
Cannabis sativa
Chronic pain treatment
Review.
Fitofármacos
Cannabis sativa
Tratamiento del dolor crónico
Revisión.
Fitofármaco
Cannabis sativa
Tratamento dor crônica
Revisão.
description The aim was to analyze the use of cannabidiol as a medicinal treatment for chronic pain by means of an integrative review. This is an Integrative Literature Review (ILR), which set out to identify, synthesize and carry out an extended analysis of the herbal use of cannabidiol. Thirty pieces of literature were selected for full reading and presentation of the results, as they met the objectives. The samples came from 85% of the Medline/PubMed database, in the last five years, with 60% of them using a cross-sectional approach and descriptive nature, and 84% of the patients studied in the studies reported an improvement in the level of chronic and/or neuropathic pain after starting to use Cannabis. In addition to this benefit, others mentioned in the articles were improved sleep and its quality, as well as reduced opioid consumption. With regard to the origin of the pain, half said it was linked to one or more causes, and chronic pain including cancer (nonspecific, intractable and other) was the most mentioned (80%). There is important consensus that medical cannabis can be approved for populations with inflammatory, nociplastic, neuropathic and mixed pain, however, if you are considering using CBD to treat chronic pain or any other MMJ-based condition, it is essential to discuss this with a doctor or healthcare professional to ensure that it is safe and appropriate for your specific situation. In this sense, more studies should be carried out to prove the importance and effectiveness of cannabidiol in the treatment of chronic pain, both from a clinical, review and statistical point of view.
publishDate 2024
dc.date.none.fl_str_mv 2024-01-27
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/44866
10.33448/rsd-v13i1.44866
url https://rsdjournal.org/index.php/rsd/article/view/44866
identifier_str_mv 10.33448/rsd-v13i1.44866
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/44866/35842
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 13 No. 1; e12413144866
Research, Society and Development; Vol. 13 Núm. 1; e12413144866
Research, Society and Development; v. 13 n. 1; e12413144866
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052637356490752